These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6028049

  • 1. Collagen-like fragments: excretion in urine of patients with Paget's disease of bone.
    Krane SM, Muñoz AJ, Harris ED.
    Science; 1967 Aug 11; 157(3789):713-6. PubMed ID: 6028049
    [Abstract] [Full Text] [Related]

  • 2. Urinary polypeptides related to collagen synthesis.
    Krane SM, Muñoz AJ, Harris ED.
    J Clin Invest; 1970 Apr 11; 49(4):716-29. PubMed ID: 4315304
    [Abstract] [Full Text] [Related]

  • 3. Polymorphism of urinary 4-hydroxyproline-containing polypeptides.
    Szymanowicz A.
    J Chromatogr; 1981 Sep 11; 225(1):55-63. PubMed ID: 7298759
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb 11; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep 11; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Relations between urine excretion of hydroxyproline and alkaline serum phophatase in Paget's disease as expression of changes in collagen metabolism].
    Mühlbach R.
    Beitr Orthop Traumatol; 1966 Apr 11; 13(4):189-96. PubMed ID: 5927636
    [No Abstract] [Full Text] [Related]

  • 16. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM, Kantrowitz FG, Byrne M, Pinnell SR, Singer FR.
    J Clin Invest; 1977 May 11; 59(5):819-27. PubMed ID: 404321
    [Abstract] [Full Text] [Related]

  • 17. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr 11; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence of a generalised connective-tissue defect in Paget's disease of bone.
    Francis MJ, Smith R.
    Lancet; 1974 May 04; 1(7862):841. PubMed ID: 4132793
    [No Abstract] [Full Text] [Related]

  • 20. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar 04; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.